| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |